List view / Grid view
1 September 2015 | By Nick Jackson
Abbott has announced positive one-year clinical results from ABSORB Japan, a multi-center, randomised trial comparing the safety and effectiveness of Abbott's fully dissolving AbsorbTM heart stent to XIENCE®...
1 September 2015 | By Nick Jackson
As a precursor to the Phase III trial, this Phase IIb study will select the optimum dose, and is being conducted in Germany under the Therapy Allergens Ordinance (Therapieallergene-Verordnung)...
28 August 2015 | By Victoria White
Mylan's proposed acquisition of Perrigo received the approval of two-thirds of the votes cast by Mylan shareholders at an extraordinary general meeting...
28 August 2015 | By Victoria White
Repatha, the second drug approved in a new class of drugs known as PCSK9 inhibitors, has been approved by the FDA for some patients who are unable to get their LDL cholesterol under control with current treatment options...
28 August 2015 | By Victoria White
Novartis has renewed its pledge with the World Health Organisation (WHO) to work to end leprosy by extending its donation of multidrug therapy medicines...
28 August 2015 | By Victoria White
Celgene has completed its acquisition of Receptos, significantly enhancing Celgene’s Inflammation & Immunology pipeline with the addition of Ozanimod...
28 August 2015 | By Victoria White
CPhI Worldwide will once again be preceded by the Pre-Connect Congress when the global pharma community returns to Madrid October 13-15th...
27 August 2015 | By Nick Jackson
Synjardy approval was based on multiple clinical trials showing reductions in blood glucose versus placebo...
27 August 2015 | By Nick Jackson
HRA Pharma UK and Ireland has announced the launch of ellaonepharmacist.co.uk, a brand new website designed specifically for healthcare professionals which provides an educational resource for ellaOne® (30mg ulipristal acetate) accessible anytime.
27 August 2015 | By Nick Jackson
Ablynx has announced its business update and results for the six-month period ending 30 June 2015...
27 August 2015 | By Nick Jackson
New treatment option for patients with difficult-to-treat form of skin cancer has shown improved treatment outcomes...
26 August 2015 | By Victoria White
The US Food and Drug Administration (FDA) has approved Praluent (alirocumab) Injection - the first and only PCSK9 inhibitor approved in the US...
26 August 2015 | By Victoria White
Alvogen is to acquire four pharmaceutical products from Pfizer, strengthening Alvogen’s commercial platform in the US market...
26 August 2015 | By Victoria White
Alliance Foundation Trials, the Austrian Breast & Colorectal Cancer Study Group and Pfizer have launched the Palbociclib Collaborative Adjuvant Study...
26 August 2015 | By Victoria White
NICE has recommended Vedolizumab, the first gut-selective treatment for Crohn's Disease, for use on the NHS, recognising the innovation of the treatment...
